top of page

Skip the 90-day Wait: When a Finished Formula Makes Sense for Your Next SKU

21 hours ago
3 min read

Updated: 14 hours ago

Fast lane sign in an airport

Cognitive Blend bottled supplement

You've been tasked with adding a new product to your catalogue and a given a launch date that seems impossible to hit. You know that a new supplement SKU typically takes at least 90 days to be made into a finished product. Some of that time is unavoidable: formulation, sourcing, testing, production. But some of it is spent building a formula you may not need to build.


That's when you decide to look at using a stock formula.


What a stock formula is

A stock formula is a finished, tested supplement that a contract manufacturer owns and already makes. It's a great starting point for your product and comes with many benefits:


  1. Speed to market. There’s no R&D phase. Brands can often go from selection to finished product in weeks rather than the months a custom formulation takes.

  2. Lower cost. Development costs (formulation, stability testing, trial batches) are already absorbed, and the manufacturer has usually already optimized sourcing.

  3. Lower minimum order quantities. Because the manufacturer buys raw materials and runs the process at scale for many customers, smaller brands can often order smaller runs.

  4. Lower risk. Manufacturability, flowability, encapsulation behavior, stability, and shelf life are already known. That reduces the chance of failed batches or reformulation surprises.

  5. Established compliance. Ingredient doses, supplier qualifications, and testing methods are already in place. That’s a big help for GMP and certification programs like NSF, and it supports label claims and Supplement Facts panels that have already been reviewed.

  6. Reliable supply chain. Raw material suppliers are already vetted, and the manufacturer buys in volume, which helps with consistency and lead times.

  7. Easier testing of the market. A brand can validate demand with a stock formula before investing in a proprietary one.


Stock or custom: how to decide

Question

Stock Formula

Custom Formula

Is speed to market the priority?

Do you need a specific ingredient profile or dose?

Is this a line extension or a test of a new category?

Is the formula part of your brand's identity?

Do you want to see finished product quality before committing?


If your answers split down the middle, start with stock and customize from there. You'll have something real in your hands sooner.


Test the manufacturer, not just the product

Most established brands already have a manufacturer, and most are happy with them until something goes wrong. A late order. A failed batch. A call that goes unreturned.


A finished stock formula is a low-pressure way to see how a second manufacturer actually works. You can evaluate:


  • Quality: Compare finished product against what you make today.

  • Communication: How fast do we respond? How clear are we?

  • Documentation: What paperwork comes with the product?


This is the same logic behind a backup manufacturer. You don't switch. You find out whether you could, before you have to.


What to ask any manufacturer about stock formulas

  1. Is the formula customizable, and where does customization begin?

  2. What are the minimum order quantities?

  3. What testing and documentation come with the finished product?

  4. Can I get a sample first? (Charges may apply.)

  5. How long from approval to delivery, and does it change if I customize?


We're happy to answer these. We'd rather you ask than guess.


Canyonside Labs employees

See one in action

Our cognitive formula is both a stock formula and a stock product. It's already made, in 90-count bottles, ready for your label. If you want to talk about label-and-ship at lower MOQs, our sales team can walk you through it. You can see the full Supplement Facts panel and details on the landing page, or book time with our business development team.


Let Canyonside Labs help you hit launch dates with stock formulas and products.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page